Ranbaxy loses to Pfizer in Lipitor case in D. Delaware
Remember the article by Sue Reisinger on Ranbaxy's challenge to Pfizer's Lipitor (covered on IPBiz in December 2004. Well, things did not work out so well for Ranbaxy in the Delaware district court:
"The court will enter judgment in favor of Pfizer and against Ranbaxy on Pfizer's claims of infringement," Judge Joseph Farnan wrote in a 66-page decision.
The decision, which lifted Pfizer shares 10 percent, dealt a setback to Indian drug maker Ranbaxy Laboratories Ltd which had hoped to introduce the cheaper copycat as soon as 2008.
Be careful in what you read, and in what you believe!
"The court will enter judgment in favor of Pfizer and against Ranbaxy on Pfizer's claims of infringement," Judge Joseph Farnan wrote in a 66-page decision.
The decision, which lifted Pfizer shares 10 percent, dealt a setback to Indian drug maker Ranbaxy Laboratories Ltd which had hoped to introduce the cheaper copycat as soon as 2008.
Be careful in what you read, and in what you believe!
posted by Lawrence B. Ebert at 4:27 PM
0 Comments:
Post a Comment
<< Home